Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_03568
Species: Homo sapiens
Position : chr3:172549013-172551013
Year: 2023
Title: An enhancer variant associated with breast cancer susceptibility in Black women regulates TNFSF10 expression and antitumor immunity in triple-negative breast cancer.
Genome Build: hg38
Enhancer Type: Enhancer
Condition: Disease
Disease Name: triple-negative breast carcinoma
PMID:  35930348
MONDO: MONDO:0005494
Tissue: breast
Tissue Ontology ID: UBERON:0000310
Cell Source: HCC1806
CVCL ID: CVCL_1258
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Enhancer variant functional assay; TF binding assay; genome editing assay
High Throughput Method: GWAS; eQTL analysis; ENCODE epigenomic data analysis
Low Throughput Method: CRISPR-Cas9 HDR editing; EMSA; supershift assay; RT-qPCR; Western blot; apoptosis assay
About Target Gene
Target gene : TNFSF10
About TF
TF name : MYB
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
MYB AP-1 transcription factor network pid 71
MYB C-MYB transcription factor network pid 87
MYB Factors involved in megakaryocyte development and platelet production reactome 111
MYB IL2 signaling events mediated by PI3K pid 38
MYB IL4-mediated signaling events pid 66
MYB Notch-mediated HES/HEY network pid 48
MYB Prolactin netpath 105
MYB Hs_Neural_Crest_Differentiation_WP2064_79263 wikipathways 40
Enhancer Associated Network
Overlapping Enhancers (hg38)
No overlapping enhancers found in hg38 at this locus.
Expression of Target Genes for the Enhancer